Power Law company profile

Mersana Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2005 · IPO 2017 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$91M

Market cap · Jan/2026

Revenue

$40M

Latest reported FY

Investors

11 investors on Mersana Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Series B+ 8 investors entered at this stage

Global footprint

Web traffic by country

1.3K monthly visits
across markets

🇺🇸 United States92.3%

🇹🇷 Turkey7.7%

Top 2 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo